Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) PT at $16.79

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have earned an average rating of “Moderate Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $16.7857.

Several research analysts recently weighed in on the stock. Leerink Partners boosted their price objective on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a research report on Friday, September 5th. Zacks Research upgraded shares of Pediatrix Medical Group to a “strong-buy” rating in a research report on Monday, August 11th. Finally, UBS Group boosted their price objective on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a “neutral” rating in a research report on Thursday, August 14th.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in MD. GAMMA Investing LLC boosted its stake in shares of Pediatrix Medical Group by 219.5% during the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock worth $37,000 after buying an additional 1,765 shares during the last quarter. Marshall & Sullivan Inc. WA acquired a new stake in Pediatrix Medical Group in the 2nd quarter valued at about $41,000. Canada Pension Plan Investment Board acquired a new stake in Pediatrix Medical Group in the 2nd quarter valued at about $83,000. AlphaQuest LLC lifted its stake in Pediatrix Medical Group by 16.0% in the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company’s stock valued at $85,000 after purchasing an additional 811 shares during the last quarter. Finally, Quantbot Technologies LP acquired a new stake in Pediatrix Medical Group in the 2nd quarter valued at about $99,000. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Down 2.2%

MD stock opened at $16.60 on Monday. Pediatrix Medical Group has a twelve month low of $10.29 and a twelve month high of $17.67. The company has a market cap of $1.45 billion, a PE ratio of 12.87 and a beta of 1.30. The business’s 50-day simple moving average is $14.62 and its 200 day simple moving average is $14.16. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.11. The firm had revenue of $468.84 million during the quarter, compared to analysts’ expectations of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company’s revenue for the quarter was down 7.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.34 earnings per share. On average, research analysts anticipate that Pediatrix Medical Group will post 1.38 earnings per share for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.